Romanian authorities are making sustained efforts to avoid downgrading the country's rating to 'junk' (speculative investments) category, which would hinder access to financial markets and increase borrowing costs for both the state and companies.
Banks in Central Eastern South-Eastern Europe report improving trends, with credit demand remaining robust, particularly from companies, while banks anticipate improvement in credit supply following a period of contraction.
BRD Group's net result amounted to RON 1.524 billion, compared to RON 1.656 billion in 2023. BRD's capital adequacy ratio on an individual level is 23%.
The average instalment for buying a one-bedroom apartment in Bucharest came to hold a percentage of about 40% of the average wage at a national level, down from 43% a year ago.
Refinancing a mortgage loan today by switching to a fixed interest rate can bring a 22.5% decrease in the monthly installment paid compared to the value registered a year ago.
Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.